Media and News

PharmaNova to exhibit at AAPS Annual Convention, Atlanta, GA.  November 16-20, 2008.

PharmaNova Inc. will be exhibiting at the AAPS Annual Convention to be held in Atlanta’s Georgia World Congress Center November 16-20.  Our display will be housed in booth #765.


The event attracts thousands of business representatives and scientists from pharmaceutical manufacturing and allied support industries, as well as from the FDA and other international regulatory agencies.  The convention provides an opportunity for PharmaNova to discuss the potential for partnerships and alliances across the globe.  Materials will be provided by PharmaNova at the exhibiting booth.  Pharmaceutical and Business Development personnel from PharmaNova will be in attendance to address all inquiries.  Come visit and learn more of our technology base and partnering opportunities.


Company Overview

PharmaNova Inc. is a privately held, specialty drug development company founded on the re-purposing and enhancement of known drugs using our proprietary nanoparticle and complementary formulation technologies. We specialize in low risk, fast to market products and generate revenue from partnering and licensing strategies with commercialization partners worldwide. PharmaNova’s current focus is on extraordinary value products in Women’s Health and adjacent areas, including a non-hormonal treatment for hot flashes associated with the menopause and for vasomotor symptoms secondary to the treatment of certain cancers. PharmaNova’s precision NovaSperseSM technology offers new opportunities for the improvement of bio-pharmaceutical properties of a wide range of poorly soluble drugs, including anti-infectives.

« Back to Media

Member of the media wishing to learn more about Pharmanova should contact:
Rafael Larramendi, President | | (585) 919 -9649.